VALEANT PHARMACEUTICALS INTERNATIONAL·4

Feb 13, 4:15 PM ET

Karlson Elisa A. 4

4 · VALEANT PHARMACEUTICALS INTERNATIONAL · Filed Feb 13, 2009

Insider Transaction Report

Form 4
Period: 2008-05-20
Karlson Elisa A.
EVP, Chief Admin Officer
Transactions
  • Award

    Common Stock

    [F1]
    2008-05-20+49,84749,847 total
Footnotes (1)
  • [F1]These restricted stock units are subject to specified performance criteria tied to total shareholder return as measured on certain specified dates.
Signature
By: Pamela Chronister Lewis For: Elisa A. Karlson|2009-02-13

Documents

2 files
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24

    EDGAR SUPPORTING DOCUMENT